Close Menu
Home › About Us › Our Staff › Turna Ray

Turna Ray

Managing Editor, Precision Oncology News
Phone Number
+1-212-651-5626
Email
[email protected]
Turna Ray at Genomeweb / 360dx Turna Ray at Genomeweb / 360dx

Turna Ray has been covering the personalized medicine and molecular diagnostics industries for GenomeWeb since 2006. She closely tracks the evolving regulatory, reimbursement, and business environment for precision medicine products. 

Articles Authored by Turna Ray

Jan 27, 2020

Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers

Premium

The findings should spur cancer centers to review testing rates and address barriers, said experts from Hackensack University, Cota Healthcare, and Guardant Health. 

Jan 09, 2020

With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

Premium

In seven years, the public variant classification database has steadily become a resource that labs are submitting to and that genetics experts are consulting.

Jan 02, 2020

Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

Premium

Despite the availability of more precision therapies and complex biomarker tests, systemic gaps and lack of physician education continued to hinder access.

Dec 12, 2019

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Absent sufficient evidence to support genetic testing for all patients, the group recommended following existing guidelines, which are based on clinical factors.

Dec 12, 2019

Universal Genetic Testing in Breast Cancer May Result in More Harm Than Good, Experts Worry

Premium

Amid rapid adoption of multi-gene panels, ACMG experts are seeing some doctors and patients taking actions they shouldn't.

Dec 11, 2019

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

In a proof-of-principle study, Ohio State University researchers compared the nanopore sequencing assay to short-read sequencing and capillary electrophoresis.

Nov 25, 2019

Mayo Tells Supreme Court Congress Should Clarify Patent Eligibility Confusion in Diagnostics

Premium

Athena and its supporters have asked the Supreme Court to clarify patent eligibility, but Mayo recently countered that this is a job for legislators.

Nov 15, 2019

Employee Benefits Programs Share Early Experiences Implementing Genetic Testing

Premium

Despite the step-up in FDA action against labs offering PGx tests, the success of these programs suggests that access to them isn't being stifled as some feared.

Nov 12, 2019

Bristol-Myers, PathAI Show Artificial Intelligence Is on Par With Manual PD-L1 Scoring

Premium

The results are of interest to drugmakers looking for scalable technology solutions for assessment of PD-L1 for predicting immunotherapy response.

Oct 22, 2019

Report Says Many Precision Drugs Will Launch in Coming Years But Unclear if They Will Reach Patients

Premium

Diaceutics is projecting that FDA will soon approve more personalized drugs than all-comer drugs, but absent changes in diagnostics strategies many patients won't receive them.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.